274 related articles for article (PubMed ID: 31659560)
1. The various therapeutic applications of the medical isotope holmium-166: a narrative review.
Klaassen NJM; Arntz MJ; Gil Arranja A; Roosen J; Nijsen JFW
EJNMMI Radiopharm Chem; 2019 Aug; 4(1):19. PubMed ID: 31659560
[TBL] [Abstract][Full Text] [Related]
2. Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applications.
Zielhuis SW; Seppenwoolde JH; Bakker CJ; Jahnz U; Zonnenberg BA; van het Schip AD; Hennink WE; Nijsen JF
J Biomed Mater Res A; 2007 Sep; 82(4):892-8. PubMed ID: 17335019
[TBL] [Abstract][Full Text] [Related]
3. Holmium-166 Microsphere Radioembolization of Hepatic Malignancies.
Reinders MTM; Smits MLJ; van Roekel C; Braat AJAT
Semin Nucl Med; 2019 May; 49(3):237-243. PubMed ID: 30954190
[TBL] [Abstract][Full Text] [Related]
4. Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres.
Roosen J; Arntz MJ; Janssen MJR; de Jong SF; Fütterer JJ; Overduin CG; Nijsen JFW
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771626
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Radioembolization with
Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy.
Arranja AG; Hennink WE; Chassagne C; Denkova AG; Nijsen JFW
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110244. PubMed ID: 31753348
[TBL] [Abstract][Full Text] [Related]
7. Microsphere radioembolization of liver malignancies: current developments.
Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
[TBL] [Abstract][Full Text] [Related]
8. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice.
Radosa CG; Radosa JC; Grosche-Schlee S; Zöphel K; Plodeck V; Kühn JP; Kotzerke J; Hoffmann RT
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):405-412. PubMed ID: 30603976
[TBL] [Abstract][Full Text] [Related]
9. Dedicated holmium microsphere administration device for MRI-guided interstitial brain microbrachytherapy.
de Vries M; Klaassen NJM; Morsink NC; van Nimwegen SA; Nijsen JFW; van den Dobbelsteen JJ
Med Eng Phys; 2021 Oct; 96():13-21. PubMed ID: 34565548
[TBL] [Abstract][Full Text] [Related]
10. Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application.
Zielhuis SW; Nijsen JF; de Roos R; Krijger GC; van Rijk PP; Hennink WE; van het Schip AD
Int J Pharm; 2006 Mar; 311(1-2):69-74. PubMed ID: 16439073
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.
Seevinck PR; van de Maat GH; de Wit TC; Vente MA; Nijsen JF; Bakker CJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e437-44. PubMed ID: 22633554
[TBL] [Abstract][Full Text] [Related]
12. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral injection of radioactive holmium (
van Nimwegen SA; Bakker RC; Kirpensteijn J; van Es RJJ; Koole R; Lam MGEH; Hesselink JW; Nijsen JFW
Vet Comp Oncol; 2018 Mar; 16(1):114-124. PubMed ID: 28480610
[TBL] [Abstract][Full Text] [Related]
14. Surface characteristics of holmium-loaded poly(L-lactic acid) microspheres.
Zielhuis SW; Nijsen JF; Figueiredo R; Feddes B; Vredenberg AM; van het Schip AD; Hennink WE
Biomaterials; 2005 Mar; 26(8):925-32. PubMed ID: 15353204
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Holmium-166 Labelled Macroaggregates for radionuclide synovectomy.
Kropácek M; Melichar F; Henková K; Konopková M
Nucl Med Rev Cent East Eur; 2003; 6(1):1-4. PubMed ID: 14600925
[TBL] [Abstract][Full Text] [Related]
16. Additional hepatic
Braat AJAT; Kwekkeboom DJ; Kam BLR; Teunissen JJM; de Herder WW; Dreijerink KMA; van Rooij R; Krijger GC; de Jong HWAM; van den Bosch MAAJ; Lam MGEH
BMC Gastroenterol; 2018 Jun; 18(1):84. PubMed ID: 29902988
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.
Kim JK; Han KH; Lee JT; Paik YH; Ahn SH; Lee JD; Lee KS; Chon CY; Moon YM
Clin Cancer Res; 2006 Jan; 12(2):543-8. PubMed ID: 16428498
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Monte Carlo-based holmium-166 SPECT reconstruction.
Elschot M; Smits ML; Nijsen JF; Lam MG; Zonnenberg BA; van den Bosch MA; Viergever MA; de Jong HW
Med Phys; 2013 Nov; 40(11):112502. PubMed ID: 24320461
[TBL] [Abstract][Full Text] [Related]
19. Radionuclide liver cancer therapies: from concept to current clinical status.
Vente MA; Hobbelink MG; van Het Schip AD; Zonnenberg BA; Nijsen JF
Anticancer Agents Med Chem; 2007 Jul; 7(4):441-59. PubMed ID: 17630919
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
